Viraleze 2021 - 2024 so you don’t often write on stocks you...

Viraleze 2021 - 2024

so you don’t often write on stocks you don’t hold

The situation with SPL is that for a few months in 2021 following great results by Scripp Research Institute https://www.scripps.edu/gallay/sars-cov-2.html

and approval in late 2020 by European EMA as medical device, there was the likelihood of massive worldwide sales of a safe cheap effective Covid presentative and treatment. In May 2021 when the stock market was still excited by prospects this channel 7 news item summarised the situation https://www.facebook.com/share/v/btDV6Q3zXSpW4NZc/?

In Canada something similar was happening, they were developing another antiviral nasal spray SaNOtize- nitric oxide almost as effective as Astodrimer sodium and similar timeframe. But neither were Big Pharma and although a little late in the field Pfizer was developing an antiviral DRUG PF-07321332 later known as Paxlovid. Phase 1 trials for PF-07321332 began late March 2021 just as Viraleze sales in UK were escalating. Two things happened. Morrison secret second Health Minister was desparate for pariah AZ vax to be replaced by Pfizer mRNA having not preordered in Sept 2020 (no large Australian deliveries of mRNA secured until Dec 2021) and an overnight meeting with Pfizer CEO occurred 8 April 2021. We don’t know what big pharma influencing was brought to bear in fledging post BREXIT separation UK MHRA but suddenly this simple safe effective medical device for pharmacy, supermarket and online marketing with customer reviews 5 , was identified in UK as making unsubstantiated claims re covid. That was June 21 (SPL.ax sinks March to June 2021 by almost 50%) then the nail in the coffin 2 July 2021 the country of origin Australia bans and fines SPL for supposedly advertising via international marketing website and ASX statements, when many other therapeutic goods can be brought into Australia under TGAs legal personal importation scheme. Soon Google was broadcasting this hit on Viraleze to the world raising questions about was Viraleze safe (anyone with a marketing background knows safety is a product killer!!). Was it another fake Covid preventative treatment like ivermectin/hydroxichloriquine - the antivaxers alternative to vaccines for Covid where Pfizer was leading the market. If Paxlovid was going to follow the gravy train of vaccines with treatment where the DRUG would be expensive and need to be bought big into national stockpiles across the world then something must be done before Viraleze and SaNOtise stole the market by MD antiviral nasal sprays GAZUMPING the late to market DRUG Paxlovid. Pfizer had already experienced competition in Bacterial vaginosis market where VivaGel over the counter could achieve the worldwide goal of reducing antibiotic use and Pfizer in US was the prime BV antibiotic maker. FDA delays whilst 40 regulators including TGA approved Astodrimer sodium Bacterial vaginosis as non absorbed MD. The safety of VivaGel in vaginal mucosa had good trials about 2018 with no Astodrimer sodium passing into bloodstream. … nasal mucosa would almost certainly be similar.

So that power and influence (particularly financial regulator and politician) in the pandemic was able to be used. By 2022 profit of $22billion for Pfizer Paxlovid with dubious escalated approval EUA

Mostly in US and Australia only nasal sprays pre pandemic were on sale with no mention of Covid like ‪carrageenan‬ FLO TRAVEL. Pfizer got the clear accelerated path for $AU1114 Paxlovid and the one product which would have continued the early 2021 share price rise of SPL was killed by mid 2021. There would be no early turnaround approvals when TGA insisted new application was to be medicine AND big trials and NO advertising (convenient if competing with AV DRUGS …)

SO with no potential to buy and destroy Viraleze the next best was no approve for a very long time until post pandemic.

4 years the population could have been helped with Viraleze and many deaths in aged care, older and younger people and long COVID avoided

so the SPL financial tragedy is also a human tragedy. With the demise of “competing” drug Lagevrio- our doctors in Australia have nothing for Covid cases

How much will turn around with the anticipated Astodrimer sodium nasal spray listing on Australian Register of Therapeutic Goods ARTG in August or September this year will be interesting but that initial March 2021 excitement is likely not to be recovered